BACKGROUND: We have previously reported that an early initiation of highly active antiretroviral therapy (HAART) in HIV-1 vertically infected children enhanced the function of memory B-cells gained during childhood routine vaccinations. On the other hand, a significant waning of immunity was observed for patients with a late treatment. In this follow-up study, we report data from a sample of patients in our cohort including late-treated patients being revaccinated with routine childhood vaccines. METHODS: The levels of serum antibodies and cellular immunity were measured by antigen-specific enzyme-linked immunosorbent assay and B-cell ELISpot. Moreover, flow cytometry on the frequencies of mature-activated (CD10-CD21-) and double-negative (CD27-IgD-) B-cells as hallmarks of immune activation and immune senescence, respectively, was performed for all patients. RESULTS: Reduced protective humoral immunity and cellular immunity to routine childhood vaccines was observed in late-treated patients. Moreover, we found that timing of HAART related with the frequencies of mature activated and double negative. CONCLUSIONS: Altogether the data presented in this follow-up study reenforce the importance for an early start of HAART in HIV-1 vertically infected individuals and suggest that timing of HAART is a fundamental factor to take into account for vaccination design in this population.
BACKGROUND: We have previously reported that an early initiation of highly active antiretroviral therapy (HAART) in HIV-1 vertically infectedchildren enhanced the function of memory B-cells gained during childhood routine vaccinations. On the other hand, a significant waning of immunity was observed for patients with a late treatment. In this follow-up study, we report data from a sample of patients in our cohort including late-treated patients being revaccinated with routine childhood vaccines. METHODS: The levels of serum antibodies and cellular immunity were measured by antigen-specific enzyme-linked immunosorbent assay and B-cell ELISpot. Moreover, flow cytometry on the frequencies of mature-activated (CD10-CD21-) and double-negative (CD27-IgD-) B-cells as hallmarks of immune activation and immune senescence, respectively, was performed for all patients. RESULTS: Reduced protective humoral immunity and cellular immunity to routine childhood vaccines was observed in late-treated patients. Moreover, we found that timing of HAART related with the frequencies of mature activated and double negative. CONCLUSIONS: Altogether the data presented in this follow-up study reenforce the importance for an early start of HAART in HIV-1 vertically infected individuals and suggest that timing of HAART is a fundamental factor to take into account for vaccination design in this population.
Authors: Jason F Okulicz; Tuan D Le; Brian K Agan; Jose F Camargo; Michael L Landrum; Edwina Wright; Matthew J Dolan; Anuradha Ganesan; Tomas M Ferguson; Davey M Smith; Douglas D Richman; Susan J Little; Robert A Clark; Weijing He; Sunil K Ahuja Journal: JAMA Intern Med Date: 2015-01 Impact factor: 21.873
Authors: Murli U Purswani; Brad Karalius; Tzy-Jyun Yao; D Scott Schmid; Sandra K Burchett; George K Siberry; Kunjal Patel; Russell B Van Dyke; Ram Yogev; Robert H Lurie; Ram Yogev; Margaret Ann Sanders; Kathleen Malee; Scott Hunter; William Shearer; Mary Paul; Norma Cooper; Lynnette Harris; Murli Purswani; Mahboobullah Baig; Anna Cintron; Ana Puga; Sandra Navarro; Patricia Garvie; James Blood; Sandra Burchett; Nancy Karthas; Betsy Kammerer; Andrew Wiznia; Marlene Burey; Molly Nozyce; Arry Dieudonne; Linda Bettica; Susan Adubato; Janet Chen; Maria Garcia Bulkley; Latreaca Ivey; Mitzie Grant; Katherine Knapp; Kim Allison; Megan Wilkins; Midnela Acevedo-Flores; Heida Rios; Vivian Olivera; Margarita Silio; Medea Jones; Patricia Sirois; Stephen Spector; Kim Norris; Sharon Nichols; Elizabeth McFarland; Alisa Katai; Jennifer Dunn; Suzanne Paul; Gwendolyn Scott; Patricia Bryan; Elizabeth Willen Journal: Clin Infect Dis Date: 2015-09-18 Impact factor: 9.079
Authors: Stefano Rinaldi; Suresh Pallikkuth; Mark Cameron; Lesley R de Armas; Nicola Cotugno; Vinh Dinh; Rajendra Pahwa; Brian Richardson; Shelly R Saini; Salvatore Rocca; Maria G Lain; Sion L Williams; Paolo Palma; Savita Pahwa Journal: J Immunol Date: 2019-12-30 Impact factor: 5.422
Authors: Lin Chen; Jiezhe Yang; Renjie Zhang; Yun Xu; Jinlei Zheng; Jianmin Jiang; Jun Jiang; Lin He; Ning Wang; Philip Chun Yeung; Xiaohong Pan Journal: AIDS Res Ther Date: 2015-09-25 Impact factor: 2.250
Authors: Margherita Doria; Sonia Zicari; Nicola Cotugno; Sara Domínguez-Rodríguez; Alessandra Ruggiero; Giuseppe R Pascucci; Alfredo Tagarro; Pablo Rojo Conejo; Eleni Nastouli; Kathleen Gärtner; Mark Cameron; Brian Richardson; Caroline Foster; Sion L Williams; Stefano Rinaldi; Anita De Rossi; Carlo Giaquinto; Paolo Rossi; Savita Pahwa; Paolo Palma Journal: J Int AIDS Soc Date: 2021-07 Impact factor: 5.396